- call +1-201-465-4211
- email sales@mrinsights.biz
Polycystic ovary syndrome is a hormonal disorder observed in females of reproductive ages.
Scope of the Report:
Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth. Moreover, increasing genetic and hormonal disorder in female population is a major cause for the increase of polycystic ovary syndrome patients across the globe.
The global Polycystic Ovary Syndrome market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Polycystic Ovary Syndrome.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Polycystic Ovary Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Polycystic Ovary Syndrome market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Addex therapeutics
Himalaya
Astellas Pharma
AstraZeneca
Ava Science
Bayer
Bristol-Myers Squibb
Theralogix
Ferring Pharmaceuticals
Teva Pharmaceutical
GSK
Sneha Natura
Jarrow Formulas
Merck
Millendo Therapeutics
MyOva
Novartis
Ogeda
PCOS Diva
Pharmasure
Salveo Lifecare
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diuretics
Insulin sensitizing agents
Antiandrogens
Anti-depressants
Ornithine decarboxylase inhibitors
Anti-obesity
Oral contraceptive pills
Market Segment by Applications, can be divided into
Hospital pharmacies
Drug stores
Retail pharmacies
Fertility clinics
e-commerce
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Polycystic Ovary Syndrome Market Overview
1.1 Product Overview and Scope of Polycystic Ovary Syndrome
1.2 Classification of Polycystic Ovary Syndrome by Types
1.2.1 Global Polycystic Ovary Syndrome Revenue Comparison by Types (2017-2023)
1.2.2 Global Polycystic Ovary Syndrome Revenue Market Share by Types in 2017
1.2.3 Diuretics
1.2.4 Insulin sensitizing agents
1.2.5 Antiandrogens
1.2.6 Anti-depressants
1.2.7 Ornithine decarboxylase inhibitors
1.2.8 Anti-obesity
1.2.9 Oral contraceptive pills
1.3 Global Polycystic Ovary Syndrome Market by Application
1.3.1 Global Polycystic Ovary Syndrome Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital pharmacies
1.3.3 Drug stores
1.3.4 Retail pharmacies
1.3.5 Fertility clinics
1.3.6 e-commerce
1.4 Global Polycystic Ovary Syndrome Market by Regions
1.4.1 Global Polycystic Ovary Syndrome Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Polycystic Ovary Syndrome Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Polycystic Ovary Syndrome Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Polycystic Ovary Syndrome Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Polycystic Ovary Syndrome Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Polycystic Ovary Syndrome Status and Prospect (2013-2023)
1.5 Global Market Size of Polycystic Ovary Syndrome (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Polycystic Ovary Syndrome Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Addex therapeutics
2.2.1 Business Overview
2.2.2 Polycystic Ovary Syndrome Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Addex therapeutics Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.3 Himalaya
2.3.1 Business Overview
2.3.2 Polycystic Ovary Syndrome Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Himalaya Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astellas Pharma
2.4.1 Business Overview
2.4.2 Polycystic Ovary Syndrome Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astellas Pharma Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Polycystic Ovary Syndrome Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ava Science
2.6.1 Business Overview
2.6.2 Polycystic Ovary Syndrome Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ava Science Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bayer
2.7.1 Business Overview
2.7.2 Polycystic Ovary Syndrome Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Polycystic Ovary Syndrome Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.9 Theralogix
2.9.1 Business Overview
2.9.2 Polycystic Ovary Syndrome Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Theralogix Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ferring Pharmaceuticals
2.10.1 Business Overview
2.10.2 Polycystic Ovary Syndrome Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ferring Pharmaceuticals Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical
2.11.1 Business Overview
2.11.2 Polycystic Ovary Syndrome Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.12 GSK
2.12.1 Business Overview
2.12.2 Polycystic Ovary Syndrome Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 GSK Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sneha Natura
2.13.1 Business Overview
2.13.2 Polycystic Ovary Syndrome Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sneha Natura Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.14 Jarrow Formulas
2.14.1 Business Overview
2.14.2 Polycystic Ovary Syndrome Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Jarrow Formulas Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck
2.15.1 Business Overview
2.15.2 Polycystic Ovary Syndrome Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.16 Millendo Therapeutics
2.16.1 Business Overview
2.16.2 Polycystic Ovary Syndrome Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Millendo Therapeutics Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.17 MyOva
2.17.1 Business Overview
2.17.2 Polycystic Ovary Syndrome Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 MyOva Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.18 Novartis
2.18.1 Business Overview
2.18.2 Polycystic Ovary Syndrome Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Novartis Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.19 Ogeda
2.19.1 Business Overview
2.19.2 Polycystic Ovary Syndrome Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Ogeda Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.20 PCOS Diva
2.20.1 Business Overview
2.20.2 Polycystic Ovary Syndrome Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 PCOS Diva Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.21 Pharmasure
2.21.1 Business Overview
2.2.2 Polycystic Ovary Syndrome Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Pharmasure Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.22 Salveo Lifecare
2.22.1 Business Overview
2.22.2 Polycystic Ovary Syndrome Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Salveo Lifecare Polycystic Ovary Syndrome Revenue, Gross Margin and Market Share (2016-2017)
3 Global Polycystic Ovary Syndrome Market Competition, by Players
3.1 Global Polycystic Ovary Syndrome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Polycystic Ovary Syndrome Players Market Share
3.2.2 Top 10 Polycystic Ovary Syndrome Players Market Share
3.3 Market Competition Trend
4 Global Polycystic Ovary Syndrome Market Size by Regions
4.1 Global Polycystic Ovary Syndrome Revenue and Market Share by Regions
4.2 North America Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
4.3 Europe Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
4.5 South America Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
5 North America Polycystic Ovary Syndrome Revenue by Countries
5.1 North America Polycystic Ovary Syndrome Revenue by Countries (2013-2018)
5.2 USA Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
5.3 Canada Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
5.4 Mexico Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
6 Europe Polycystic Ovary Syndrome Revenue by Countries
6.1 Europe Polycystic Ovary Syndrome Revenue by Countries (2013-2018)
6.2 Germany Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
6.3 UK Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
6.4 France Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
6.5 Russia Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
6.6 Italy Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Polycystic Ovary Syndrome Revenue by Countries
7.1 Asia-Pacific Polycystic Ovary Syndrome Revenue by Countries (2013-2018)
7.2 China Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
7.3 Japan Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
7.4 Korea Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
7.5 India Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
8 South America Polycystic Ovary Syndrome Revenue by Countries
8.1 South America Polycystic Ovary Syndrome Revenue by Countries (2013-2018)
8.2 Brazil Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
8.3 Argentina Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
8.4 Colombia Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Polycystic Ovary Syndrome by Countries
9.1 Middle East and Africa Polycystic Ovary Syndrome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
9.3 UAE Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
9.4 Egypt Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
9.6 South Africa Polycystic Ovary Syndrome Revenue and Growth Rate (2013-2018)
10 Global Polycystic Ovary Syndrome Market Segment by Type
10.1 Global Polycystic Ovary Syndrome Revenue and Market Share by Type (2013-2018)
10.2 Global Polycystic Ovary Syndrome Market Forecast by Type (2018-2023)
10.3 Diuretics Revenue Growth Rate (2013-2023)
10.4 Insulin sensitizing agents Revenue Growth Rate (2013-2023)
10.5 Antiandrogens Revenue Growth Rate (2013-2023)
10.6 Anti-depressants Revenue Growth Rate (2013-2023)
10.7 Ornithine decarboxylase inhibitors Revenue Growth Rate (2013-2023)
10.8 Anti-obesity Revenue Growth Rate (2013-2023)
10.9 Oral contraceptive pills Revenue Growth Rate (2013-2023)
11 Global Polycystic Ovary Syndrome Market Segment by Application
11.1 Global Polycystic Ovary Syndrome Revenue Market Share by Application (2013-2018)
11.2 Polycystic Ovary Syndrome Market Forecast by Application (2018-2023)
11.3 Hospital pharmacies Revenue Growth (2013-2018)
11.4 Drug stores Revenue Growth (2013-2018)
11.5 Retail pharmacies Revenue Growth (2013-2018)
11.6 Fertility clinics Revenue Growth (2013-2018)
11.7 e-commerce Revenue Growth (2013-2018)
12 Global Polycystic Ovary Syndrome Market Size Forecast (2018-2023)
12.1 Global Polycystic Ovary Syndrome Market Size Forecast (2018-2023)
12.2 Global Polycystic Ovary Syndrome Market Forecast by Regions (2018-2023)
12.3 North America Polycystic Ovary Syndrome Revenue Market Forecast (2018-2023)
12.4 Europe Polycystic Ovary Syndrome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Polycystic Ovary Syndrome Revenue Market Forecast (2018-2023)
12.6 South America Polycystic Ovary Syndrome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Polycystic Ovary Syndrome Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Polycystic Ovary Syndrome Picture
Table Product Specifications of Polycystic Ovary Syndrome
Table Global Polycystic Ovary Syndrome and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
